Go Deep
Ajooni Biotech Limited
Ajooni Biotech Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Sep 2026 | 23,294 | 12.6 | 0.61 | 0.29 | 3.14 |
| Sep 2026 | 23,243 | 12.6 | 0.61 | 0.29 | 3.14 |
| Sep 2026 | 23,294 | 12.6 | 0.61 | 0.29 | 3.14 |
| Oct 2026 | 24,389 | 12.4 | 0.61 | 0.29 | 3.10 |
| Oct 2026 | 23,718 | 12.1 | 0.59 | 0.29 | 3.03 |
| Oct 2026 | 23,885 | 12.1 | 0.57 | 0.29 | 3.02 |
Ajooni Biotech Limited Quarterly Results
| Line Item | Mar 2025 |
|---|---|
| Revenue | 292,744,000.0 |
| Net Profit | 15,438,000.0 |
Ajooni Biotech Limited Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 1,823,782,000.0 | 1,146,919,000.0 | 801,146,000.0 | 744,877,000.0 | — |
| Net Profit | 43,221,000.0 | 33,723,000.0 | 21,612,000.0 | 11,247,000.0 | — |
| EPS | — | 0.2 | 0.2 | 1.5 | 0.2 |
Ajooni Biotech Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 1,203,652,000.0 | 950,511,000.0 | 475,204,000.0 | 587,314,000.0 | — |
| Total Liabilities | 291,738,000.0 | 69,723,000.0 | 48,119,000.0 | 170,621,000.0 | — |
| Total Equity | 911,914,000.0 | 880,788,000.0 | 427,085,000.0 | 416,693,000.0 | — |
Owes vs Owns
Ajooni Biotech Limited owed ₹0.24 for every ₹1 it owned in Mar 2026, down from ₹0.29 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.24× | 0.07× | 0.10× | 0.29× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Ajooni Biotech Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 1.0%Receivables 14.8%Inventory 32.8%Fixed assets (tangible) 22.9%Long-term investments 14.5%Other assets 13.7%
How it's funded — Mar 2026
Short-term debt 13.9%Long-term debt 0.8%Payables 7.4%Other liabilities 2.1%Shareholders' equity 75.8%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 1.2 | 7.5 | 0.4 | 0.8 |
| Receivables | 17.8 | 16.2 | 13.0 | 20.6 |
| Inventory | 39.5 | 24.0 | 15.4 | 7.0 |
| Fixed assets (tangible) | 27.6 | 13.6 | 12.7 | 8.1 |
| Intangible assets | 0.4 | 0.5 | 0.0 | 0.0 |
| Long-term investments | 17.4 | 18.6 | 2.1 | 15.7 |
| Other assets | 16.4 | 14.6 | 3.9 | 6.6 |
| Liabilities & equity | ||||
| Short-term debt | 16.7 | 0.7 | 0.5 | 3.4 |
| Long-term debt | 1.0 | 1.3 | 1.7 | 1.7 |
| Payables | 8.9 | 3.5 | 1.6 | 10.1 |
| Other liabilities | 2.5 | 1.5 | 1.1 | 1.8 |
| Shareholders' equity | 91.2 | 88.1 | 42.7 | 41.7 |
| Net tangible assets | 90.8 | 87.6 | 42.7 | 41.7 |
Ajooni Biotech Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | -57,341,000.0 | -319,731,000.0 | 229,101,000.0 | -55,790,000.0 | — |
| Investing Activities | -157,709,000.0 | -171,344,000.0 | 76,370,000.0 | -158,240,000.0 | — |
| Financing Activities | 150,937,000.0 | 248,264,000.0 | -35,661,000.0 | 216,550,000.0 | — |